antibody-drug binding technology
Scope
Date
~
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to develop submarine technology to evade detection
South Korea's Hanwha Ocean Co. has consecutively secured contracts for naval technology-related vessel research projects. The company recently annou...
Nov 29, 2023 (Gmt+09:00)
-
Batteries
Lotte Chem develops tech to improve EV battery durability
Lotte Chemical Corp. said on Tuesday it has developed a technology to improve the durability of electric vehicle cell materials by enhancing the sta...
Nov 28, 2023 (Gmt+09:00)
-
Metaverse
SK Telecom to expand metaverse market in SE Asia
South Korea's SK Telecom Co. announced on Monday that it partnered with three IT companies in Southeast Asia to accelerate its metaverse market st...
Nov 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung Electronics to up AI chip foundry sales to 50% by 2028
Samsung Electronics Co. plans to up artificial intelligence chip foundry sales to about 50% of its total foundry sales in five years with its advanc...
Nov 20, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Batteries
SK Ecoplant develops core battery recycling technologies
South Korea’s SK Ecoplant Co. has developed four core battery-recycling technologies, including recovering nickel and cobalt from spent lithiu...
Nov 14, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Systems to develop extra-large UUV platform technology
Hanwha Systems Co., the defense and air mobility unit of Hanwha Group, will develop technology that will pave the way for the development of Korea-m...
Nov 10, 2023 (Gmt+09:00)
-
Artificial intelligence
LG, Qraft Technologies' AI-powered ETF trades on NYSE
South Korea’s LG Group and Seoul-based Qraft Technologies Inc. have jointly launched an exchange-traded fund (ETF) that selects holdings relat...
Nov 08, 2023 (Gmt+09:00)
-
Future mobility
Hyundai's Supernal plans to build flying taxi plant in US
Hyundai Motor Group plans to build a flying electric taxi plant in the US as the South Korean automotive group aims to bring flying cars to the mark...
Nov 08, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Electronics hosts AI Forum 2023
Samsung Electronics Co. held on Tuesday the Samsung AI Forum 2023 with the theme of "Super AI for a Better Tomorrow" at the Suwon Convention Center ...
Nov 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean to join Canadian patrol submarine project
South Korea's shipbuilder Hanwha Ocean Co. secured a memorandum of understanding (MOU) with four Canadian submarine tech firms at Deep Blue Forum 20...
Nov 06, 2023 (Gmt+09:00)
-
Artificial intelligence
On-device AI chips: New battleground for chipmakers
As on-device artificial intelligence, designed for smart gadgets such as smartphones, laptops and autonomous-driving cars, emerges as a mega-trend f...
Nov 05, 2023 (Gmt+09:00)
-
Research & Development
POSCO to build 2nd N.EX.T Hub research institute in Seongnam city
POSCO Group, which owns South Korea’s largest steelmaker, plans to build a second research institute near Seoul to support the conglomerate&rs...
Nov 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Merck team up for AI tech for new drug
South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an arti...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean to design digital vessels with ABS
South Korea’s Hanwha Ocean Co. on Sunday announced its conclusion of a basic accord with the Houston-based American Bureau of Shipping (ABS) t...
Oct 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Theraject Asia applies for microneedle patent in US
South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a const...
Oct 27, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
SK Enmove, Hanwha Aerospace to develop ESS for vessels
South Korea’s lubricating oil maker SK Enmove Co. and defense industry company Hanwha Aerospace Co. will jointly develop energy storage syst...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to enter China’s botulinum toxin market with Newlux
South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cut...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Carbon neutrality
Lotte, two SK Group units to join hands for carbon capture
Lotte Chemical Corp., SK Innovation Co. and SK IE Technology Co. (SK IET) have signed a memorandum of understanding (MOU) to make their joint push i...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand